2.3x
new HIV diagnoses
2023
living with HIV
2023
PrEP usage
2023
*State/region and county/state data rounded to the nearest whole percent.
†In individuals aged 13+.
‡State/region and county/state data rounded to the nearest whole percent.
§In individuals aged 13+.
¶Refers to populations including Asian, American Indian/Alaska Native, Native Hawaiian/other Pacific Islander, or multiple races.
‡State/region and county/state data rounded to the nearest whole percent.
§In individuals aged 13+.
‡State/region and county/state data rounded to the nearest whole percent.
§In individuals aged 13+.
AIDSVu is presented by Emory University’s Rollins School of Public Health in partnership with Gilead Sciences, Inc., and the Center for AIDS Research (CFAR) at Emory University.
2.3x
(Newman DR, et al; 2020; N=211,603. Women aged 13 to 59 years; 2000-2015; Louisiana)
~4x
(Katz DA, et al; 2016; N=6,577. MSM aged 15 to 64 years; 2007-2013; Washington)
STI=sexually transmitted infection.
**Not all PrEP options can be used in cisgender women and transgender men.2
Correct!Incorrect.PrEP should be discussed with all adults and adolescents who are sexually active, including cisgender men and women, transgender men and women, and nonbinary individuals. Some PrEP options can be used in pregnant women.2
Correct!Incorrect.PrEP conversations should be prioritized in all of these populations.6-8
Correct!Incorrect.Primary care providers are discussing PrEP and accounted for 80% of PrEP prescriptions.9
References:
1. Centers for Disease Control and Prevention. US Public Health Service: Preexposure prophylaxis for the prevention of HIV infection in the United States—2021 update: a clinical practice guideline. Published December 1, 2021. Accessed June 15, 2026. https://stacks.cdc.gov/view/cdc/112360
2. Centers for Disease Control and Prevention. HIV Nexus: CDC resources for clinicians. Updated April 30, 2026. Accessed June 15, 2026. https://www.cdc.gov/hivnexus/hcp/prep/index.html
3. AIDSVu. Tools & resources. Accessed June 17, 2026. https://aidsvu.org/resources/#/datasets?data_types=prevalence. AIDSVu is presented by Emory University's Rollins School of Public Health in partnership with Gilead Sciences, Inc. and the Center for AIDS Research (CFAR) at Emory University.
4. Newman DR, Rahman MM, Brantley A, Peterman TA. Rates of new human immunodeficiency virus (HIV) diagnoses after reported sexually transmitted infection in women in Louisiana, 2000-2015: implications for HIV prevention. Clin Infect Dis. 2020;70(6):1115-1120.
5. Katz DA, Dombrowski JC, Bell TR, Kerani RP, Golden MR. HIV incidence among men who have sex with men after diagnosis with sexually transmitted infections. Sex Transm Dis. 2016;43(4):249-254.
6. Centers for Disease Control and Prevention. HIV prevention in the United States: mobilizing to end the epidemic. Published January 28, 2021. Accessed July 10, 2026. https://stacks.cdc.gov/view/cdc/103438
7. Sullivan PS, DuBose SN, Castel AD, et al. Equity of PrEP uptake by race, ethnicity, sex and region in the United States in the first decade of PrEP: a population-based analysis. Lancet Reg Health Am. 2024;33:100738.
8. Bosh KA, Hall HI, Eastham L, Daskalakis DC, Mermin JH. Morbidity and Mortality Weekly Report (MMWR): Estimated annual number of HIV infections—United States, 1981-2019. Centers for Disease Control and Prevention. Published June 4, 2021. Accessed July 10, 2026. https://www.cdc.gov/mmwr/volumes/70/wr/pdfs/mm7022a1-H.pdf
9. Data on file. Gilead Sciences, Inc.